| Laura Oliver Thomas, MD | |
|
3000 New Bern Ave, Raleigh, NC 27610-1231 | |
| (919) 350-7000 | |
| (919) 350-8959 |
| Full Name | Laura Oliver Thomas |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 34 Years |
| Location | 3000 New Bern Ave, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063438877 | NPI | - | NPPES |
| 8982828 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 0101270829 (Virginia) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 36634 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Twin County Regional Hospital | Galax, VA | Hospital |
| Wythe County Community Hospital | Wytheville, VA | Hospital |
| Wakemed, Raleigh Campus | Raleigh, NC | Hospital |
| Wilson Medical Center | Wilson, NC | Hospital |
| Wakemed, Cary Hospital | Cary, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centra Medical Group Llc | 4789606088 | 603 |
| Raleigh Radiology Llc | 6305739707 | 46 |
| Raleigh Radiology Associates Inc | 6800874611 | 60 |
| Raleigh Radiology Wakemed Imaging, Llc | 8325453459 | 36 |
| Raleigh Radiology Associates Inc | 6800874611 | 60 |
| Raleigh Radiology Llc | 6305739707 | 46 |
| Raleigh Radiology Associates Inc | 6800874611 | 60 |
| Centra Medical Group Llc | 4789606088 | 603 |
| Raleigh Radiology Associates Inc | 6800874611 | 60 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
| Entity Name | Raleigh Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952527343 PECOS PAC ID: 6305739707 Enrollment ID: O20040207000061 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
| Entity Name | Raleigh Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811920101 PECOS PAC ID: 6800874611 Enrollment ID: O20040708001403 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
| Entity Name | Raleigh Radiology Wakemed Imaging, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821694381 PECOS PAC ID: 8325453459 Enrollment ID: O20210223000224 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
| Entity Name | Wake Pet Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770182933 PECOS PAC ID: 4789084567 Enrollment ID: O20210616000744 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
| Entity Name | Centra Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20231109002936 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Oliver Thomas, MD 5220 Greens Dairy Rd, Raleigh, NC 27616-4612 Ph: (540) 493-4581 | Laura Oliver Thomas, MD 3000 New Bern Ave, Raleigh, NC 27610-1231 Ph: (919) 350-7000 |
News Archive
For people who dislike needles, medical tests that require a drop of saliva instead of a vial of blood will one day make a trip to a doctor or dentist much easier. But as scientists now construct the first of these saliva tests for early signs of cancer and other diseases, they continue to push the technological envelope in interesting ways.
Johns Hopkins researchers have developed the basis of an inexpensive, simple urine test that identifies impending kidney failure or rejection following transplant surgery. Their work, presented this week in a special invited lecture to the American Transplant Congress in Boston, Mass., is based on proteins found in urine, and could lead to a urine test kit that may allow many patients to skip painful biopsies.
A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.
Eclipsys Corp.® and Microsoft Corp. today announced they have signed an alliance agreement to deliver the choice and flexibility that hospitals need and want to improve health information technology (HIT) efficiencies. Breaking with the tradition of closed, proprietary systems, the two companies will offer the market tightly integrated health IT solutions designed to make it easy for physicians, nurses and hospital administrators to gain insights from data aggregated from multiple clinical and financial systems across the hospital.
Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.
› Verified 2 days ago
Dr. Teerath Peter Tanpitukpongse, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Blue Ridge Rd Ste 100, Raleigh, NC 27612 Phone: 919-781-1437 Fax: 919-787-4870 | |
Dennis Martin O'donnell, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3949 Browning Pl, Raleigh, NC 27609 Phone: 919-787-8221 Fax: 919-789-4461 | |
Bryan Maclin Peters, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3949 Browning Pl, Raleigh, NC 27609 Phone: 919-787-8221 Fax: 919-789-4461 | |
Dr. Rahul Arya, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-7000 Fax: 919-350-8959 | |
Sejal Narendra Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Wake Forest Rd, Raleigh, NC 27609 Phone: 919-954-3700 | |
Bryce Alan Harbertson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Wake Forest Rd, Raleigh, NC 27609 Phone: 919-954-3624 |